Dec 24, 09 | Posted by: Bayshore Pediatrics

H1N1 Recall Update

It was announced yesterday that Medimunne is recalling doses of the H1N1 nasal spray due to a small decrease  in antigen content required by the CDC and FDA.  What this means is that the strength of immunity expected has fallen or is falling slightly below the required amount.   Bayshore Pediatrics has reviewed the lot numbers attached to the H1N1 vaccine administered or scheduled to be administered.  We had received the lots associated with the recall, both having administered the lots and having lots remaining.  We have pulled the doses remaining and will not be administering these.  For those that received the doses being recalled, there is no action to be taken.  Because the vaccine is not being recalled due to safety issues, the CDC is not recommending any re-vaccination when the first doses was a recalled dose.  Rather, they continue to recommend the booster dose for children 9 years and under which can be scheduled 28 days from the first dose.  This second dose will boost the immunity to expected levels for continued protection against the H1N1 influenza illness.

No Comments »